Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Effects of Switching from Stavudine to Raltegravir on Subcutaneous Adipose Tissue in HIV-Infected Patients with HIV/HAART-Associated Lipodystrophy Syndrome (HALS). A Clinical and Molecular Study

  • Domingo Pedrol, Pedro|||0000-0003-1138-5770
  • Gutierrez, Mª del Mar|||0000-0002-0691-1206
  • Gallego-Escuredo, José Miguel
  • Torres, Ferran|||0000-0002-7355-7913
  • Mateo, María Gracia|||0000-0003-1389-9310
  • Villarroya, Joan
  • de los Santos Gil, Ignacio|||0000-0001-7073-5211
  • Domingo, Joan Carles|||0000-0002-6356-0836
  • Villarroya, Francesc|||0000-0003-1266-9142
  • Rio, Luis del
  • Estrada, Vicente|||0000-0002-7795-5986
  • Girlat, Marta|||0000-0001-7968-4190
HIV-1/HAART-associated lipodystrophy syndrome (HALS) has been associated with exposure to stavudine (d4T) through mitochondrial dysfunction. We performed a 48-week study to assess the effects of switching from d4T to raltegravir (RAL) on metabolic and fat molecular parameters of patients with HALS. Forty-two patients with HALS and a median exposure to d4T.